Related Experiment Videos
Sample size for comparing linear growth curves
1Clinical and Scientific Affairs, Central Research Division Pfizer, Inc., New York, New York 10017-5755, USA.
Journal of Biopharmaceutical Statistics
|June 24, 1999
Summary
This study provides a method for calculating sample size in clinical trials with repeated measurements. It ensures sufficient power for detecting treatment differences in exponential family data.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Longitudinal Data Analysis
Background:
- Comparing treatment efficacy often involves repeated measurements over time.
- Accurate sample size calculation is crucial for the validity and efficiency of clinical trials.
- Longitudinal data analysis requires specialized statistical methods to account for within-subject correlations.
Purpose of the Study:
- To develop a sample size computation method for comparing two treatment groups in longitudinal studies.
- To address scenarios where repeated measurements follow exponential family distributions.
- To provide a framework for sample size determination under a linear growth curve model.
Main Methods:
- Utilized a linear growth curve model with a suitable link function.
- Employed generalized estimating equations (GEE) to estimate regression parameters.
- Derived sample size based on the asymptotic normality of the difference between treatment slopes (delta).
- Incorporated dispersion matrices under null and alternative hypotheses using a working correlation matrix.
Main Results:
- A formula for sample size calculation was derived for comparing two treatment groups.
- The method is applicable to repeated measures designs with binary and count data.
- Numerical examples illustrate the practical application of the sample size computation.
Conclusions:
- The proposed method offers a statistically sound approach to sample size determination in longitudinal studies.
- This methodology facilitates robust clinical trial design for interventions with repeated outcome measures.
- The findings are particularly relevant for trials involving binary or count data analyzed using generalized linear models.